snehalshaha
10+ Views

Urology Devices Market worth $46.4 billion by 2026 - Exclusive Report by MarketsandMarkets™

Urology Devices Market by Product ((Dialysis, Endoscopes, Lasers, Lithotripsy, Robotic System), (Guidewires, Catheters, Stents)), Application(Kidney Diseases, Urological Cancer, BPH), End User(Hospital, Dialysis Center, Homecare) - Global Forecast to 2026, published by MarketsandMarkets™, the market is projected to reach USD 46.4 billion by 2026 from USD 38.0 billion in 2021, at a CAGR of 4.1%.

Browse in-depth TOC on "Urology Devices Market"
122 – Tables
36 – Figures
198 – Pages


Scope of the Report

This report categorizes the urology devices market into the following segments and subsegments:
By Product
Instruments
Dialysis Devices
Hemodialysis Devices
Peritoneal Dialysis Devices

Endoscopes
Laparoscopes
Ureteroscopes
Nephroscopes
Resectoscopes
Cystoscopes

Laser & Lithotripsy Devices
Endovision & Imaging Devices
Robotic Systems
Insufflators
Endoscopy Fluid Management Systems
Urodynamic Systems
Consumables & Accessories
Dialysis Consumables
Guidewires
Retrieval Devices & Extractors
Surgical Dissectors, Forceps, & Needle Holders
Dilator Sets & Urethral Access Sheaths
Stents
Biopsy Devices
Tubes & Distal Attachments
Drainage Bags
Other Consumables & Accessories

By Application
Kidney Diseases
Urological Cancer & BPH
Pelvic Organ Prolapse
Other Applications

By End User
Hospitals, ASCs, & Clinics
Dialysis Centers
Home Care Settings

By Region
North America
US
Canada

Europe
Germany
UK
France
Italy
Spain
Rest of Europe

Asia Pacific
China
Japan
India
Rest of Asia Pacific

Latin America
Middle East & Africa

The rising incidence and prevalence of urological conditions drives growth in the urology devices market, growing preference for minimally invasive procedures, and the growing number of hospitals and investments in endoscopy and laparoscopy facilities are among the other factors. Emerging economies such as China and Japan are providing lucrative opportunities for the players operating in the market.
The instruments segment accounted for the largest share of the urology devices market, by product segment, in 2020
Based on product, the market is segmented into instruments and consumables & accessories. The instruments segment accounted for the largest share of the market in 2020. This segment includes dialysis devices, endoscopes, laser and lithotripsy devices, robotic systems, endovision and imaging systems, insufflators, endoscopy fluid management systems, and urodynamic systems. The dialysis devices segment accounted for the largest share of the urology instruments market in 2020. The large share of this segment can be attributed to the growing patient pool of CKD due to the rising geriatric population.
Urological cancer and BPH segment to register the highest growth rate during the forecast period
The urology devices market is segmented into kidney diseases, urological cancer and BPH, pelvic organ prolapse, and other applications based on application. In 2020, the urological cancer and BPH segment accounted for the highest growth rate. This can be attributed to the rising incidence of urological cancers coupled with the growing number of cancer-related surgeries.
The hospitals, ASCs, and clinics segment accounted for the largest share of the urology devices market, by end user segment, in 2020
Based on end users, the market is segmented into hospitals, ASCs, and clinics; dialysis centers; and home care settings. In 2020, the hospitals, ASCs, and clinics segment accounted for the largest share of the market. The improving healthcare infrastructure in developing countries such as India, the rising number of target procedures, and the rising number of surgeries are the major factors driving this segments growth.
North America is the largest regional market for urology devices market
the market is segmented into five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of the urology devices market. The large share of this region can be attributed to the increasing healthcare expenditure, highly developed healthcare systems in the US and Canada, and increasing prevalence of chronic and lifestyle conditions.
The major players operating in this urology devices market are Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International Inc. (US), Boston Scientific Corporation (US), Becton, Dickinson and Company (US), Olympus Corporation (Japan), B. Braun Melsungen AG (Germany), Stryker Corporation (US), KARL STORZ (Germany), Cook Medical (US), Intuitive Surgical (US), Medtronic plc (Ireland), Cardinal Health (US), Teleflex Incorporated (US), Richard Wolf GmbH (Germany), CompactCath (US), Dornier MedTech (Germany), Nikkiso Co., Ltd. (Japan), Balton Sp. z o.o. (Poland), Dialife SA (Switzerland), Maxer Endoscopy GmbH (Germany), Vimex Sp. z o.o. (Poland), Amsino International, Inc. (US), ROCAMED (Monaco), Well Lead Medical Co., Ltd. (China), Medispec (US), Medical Technologies of Georgia (Georgia), EndoMed Systems GmbH (Germany), Hunter Urology (England), J and M Urinary Catheters LLC (US), and Ribbel International Limited (India).
Comment
Suggested
Recent
Cards you may also be interested in
Urinary Catheters Market worth $2.6 billion by 2025 - Exclusive Report by MarketsandMarkets™
According to the new market research report "Urinary Catheters Market by Product (Indwelling, Intermittent, External), Type (Coated, Uncoated), Application (Urinary Incontinence, Benign Prostate Hyperplasia, General Surgery), Usage (Male, Female), End Users (Hospitals) & Region - Global Forecast To 2025", published by MarketsandMarkets™, the global Urinary Catheters Market is projected to reach USD 2.6 billion by 2025 from USD 2.0 billion in 2020, at a CAGR of 5.5% during the forecast period. Browse in-depth TOC on "Urinary Catheters Market 125 – Tables 35 – Figures 165 – Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132934629 The growing prevalence of urinary incontinence, an increasing number of surgical procedures across the globe, high incidence of prostate cancer, and the favorable reimbursement scenario are the major factors driving the growth of this market. In 2019, the indwelling catheters segment accounted for the largest share of the urinary catheters market Based on products, the global market is segmented into indwelling catheters, intermittent catheters, and external catheters. Indwelling catheters accounted for the largest share of the market in 2019. These catheters are also widely used in high-acuity patient units, with critical care and intensive care units registering the highest usage of indwelling catheters. Growth in this market is largely driven by the cost-efficiency and high availability of indwelling catheters in the market. The coated catheter segment is expected to grow at the highest CAGR during the forecast period By catheter type, the global market is segmented into coated and uncoated catheters. Coated catheters accounted for the largest share of the market in 2019. This segment is also expected to register the highest CAGR during the forecast period. Growth in this market is mainly driven by the various advantages associated with coated catheters, such as easier, more comfortable insertion, low risk of catheter-associated urinary tract infection, reduced risk of urethral damage, and improved patient satisfaction. North America was the largest regional market for urinary catheters market in 2019 The market is segmented into four major regions—North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America was the largest regional market for urinary catheters in 2019. The large share of North America in this market can be attributed to the favorable reimbursement scenario and the rising volume of surgeries in the region. However, the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period. The high growth in this market can be attributed to the growing healthcare spending in emerging Asian countries, rising prevalence of urinary incontinence, and the large target patient population in the region. Get 10% Customization on this Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=132934629 The global urinary catheters market is highly consolidated. The prominent players operating in this market include B. Braun Melsungen AG (Germany), Boston Scientific Corporation (US), Coloplast Ltd. (Denmark), ConvaTec Inc. (UK), Becton, Dickinson and Company (US), Cardinal Health (US), Teleflex Incorporated (US), Wellspect HealthCare (US), and Cook Medical (US). Other players include Asid Bonz GmbH (Germany), Degania Silicone Ltd. (Israel), Bactiguard (Sweden), Medical Technologies of Georgia (US), ROCAMED (Monaco), Well Lead Medical Co., Ltd. (China), Go Medical Industries Pty Ltd. (Australia), Cure Medical, LLC, Amsino International, Inc. (US), Urocare Products, Inc. (US), J and M Urinary Catheters LLC. (US), CompactCath (US), Hunter Urology (England), MANFRED SAUER GMBH (Germany), and Ribbel International Limited (India). Browse Related Reports: Urology Devices Market by Product ((Endoscopes, Robotic, Lasers & Lithotripsy, Dialysis, Urodynamic Systems), (Guidewires, Catheters, Biopsy Devices)), Disease (Kidney Disease, Urologic Cancer, Pelvic Organ Prolapse), End User - Global Forecast to 2026 https://www.marketsandmarkets.com/Market-Reports/urology-devices-market-173062212.html Catheters Market by Type (Cardiovascular (IVUS Catheter, Guiding Catheter, Balloon Catheter), Urology catheter (Dialysis, Foley, Intermittent Catheter), Intravenous Catheter (Central Venous Catheter)), & End User (Hospital) - Global Forecast to 2025 https://www.marketsandmarkets.com/Market-Reports/catheters-market-6247803.html
Super Benefits of Zinc For PCOS
Zinc is an essential microelement. It implies that it is required in a small amount but its requirement is crucial and necessary for proper body functions. It assists vital body functions such as regulation of cell growth, hormone release, immunological response, and reproduction. Besides these functions, it also plays a role in recovery from PCOS and other female reproductive problems. In this article, the health crescent has signified the use of zinc for PCOS management, its benefits, sources dosage, and other important roles of zinc in the human body. Benefits of Zinc For PCOS The benefits of Zinc for PCOS are numerous to get the most out of them follow along to read about how zinc and PCOS are interrelated. Maintain blood glucose levels Zinc plays a vital role in glucose metabolism, regulation, and in forming insulin expression. Hence, its deficiency can lead to insulin resistance and type II diabetes. Therefore, proper intake of zinc in PCOS is necessary for the maintenance of blood glucose levels. Improves ovulation and fertility rate Zinc is closely associated with the female reductive system because it assists regulation of women’s reproductive hormones, for instance; LH and FSH. In this way, zinc promotes healthy ovulation and maturation of the oocyte. Related: Green Tea For PCOS Manage Hirsutism Hirsutism is the condition of having excess facial hair in females, which is the most devastating symptom of PCOS. Zin can help to manage and control hirsutism by reducing androgens such as testosterone levels in females suffering from PCOS. To prevent further facial hair growth, along with other lifestyle changes use of zinc for PCOS is essential. For Complete Article Visit: Benefits of Zinc For PCOS
CI Scientists - Pharma Competitive Intelligence | Competitive Intelligence Biotech
We are a boutique consulting firm providing competitive intelligence support to the Pharma/biotech industry. Here at CI Scientists, science is in our DNA. We inculcate the spirit of inquiry in all we do, disrupting the way CI is practiced in the Pharmaceutical/Biotech space. We are here for you anytime, always! An email or phone call away. Each day, we better our deliveries than the previous ones. Our solutions are customized with stringent process compliances in place. It helps us deliver strategic and actionable competitive insights in an efficient manner, making it a win-win story every time. Consulting services – connecting the dots from data to intelligence: a) Integrated monitoring – A continuous consulting service that monitors the market on a rolling basis, ensuring that you are aware of your competition. b) Conference intelligence – Comprehensive coverage of global scientific conferences, both on-site and virtual. c) Ad-hoc projects – Analyses ranging from promotional content, clinical trial info’, hypothesis testing, MOAs, etc., delivered with speed and accuracy. Products customized for every client: a) EazeeView – A web-based dynamic platform that hosts all your CI needs in a secure environment. b) AssetView – A 3-D, framework-based tool that enables your early-stage asset planning. c) CliniView – The in-house AI-enabled global clinical trials database. More Info : https://ciscientists.com/pharma-competitive-intelligence
Pharmaceutical Packaging Equipment Market worth $10.4 billion by 2025 - Exclusive Report by MarketsandMarkets™
According to the new market research report "Pharmaceutical Packaging Equipment Market by Product (Aseptic Packaging, Blister, Strip, Bottle, Tube, Carton, Case Packer, Wrapping Machine, Palletizing, Labeling & Serialization), Type (Tablet, Powder, Cream, Syrup, Aerosol), Region - Global Forecast to 2025", published by MarketsandMarkets™, the global Pharmaceutical Packaging Equipment Market size is projected to reach USD 10.4 billion by 2025 from USD 7.3 billion in 2020, at a CAGR of 7.4% from 2020 to 2025. Browse in-depth TOC on "Pharmaceutical Packaging Equipment Market" 276 – Tables 48 – Figures 330 – Pages Download PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=19845828 The growth of the global pharmaceutical packaging equipment industry is driven by the rapidly growing generic and biopharmaceutical markets, growth in OTC drug sales, rising need for flexible and integrated packaging equipment, increased offshore manufacturing in the pharmaceuticals market, and the introduction of regulatory standards on packaging and stringent norms against counterfeiting. Primary packaging equipment accounted for the largest share in the market in the forecast period. On the basis of product, the pharmaceutical packaging equipment market is segmented into primary packaging equipment, secondary packaging equipment, and labeling and serialization equipment. In 2019, the primary packaging equipment segment accounted for the largest share of the market. The main function of primary packaging is to restrict climatic, chemical, or biological hazards that cause deterioration. The rising need for the aseptic filling and sealing of drug molecules into sterile containers and the increasing demand for parenteral vials and prefillable syringes are supporting the growth of this segment. Liquid packaging equipment expected to show the highest growth in the forecast period. Based on type, the pharmaceutical packaging equipment market is segmented into liquid, solid, semi-solid, and other packaging equipment. In 2019, the liquid packaging equipment segment accounted for the largest share of the market, followed by solid and semi-solid packaging equipment segments. The largest share can be attributed to the wide range of applications of liquid pharmaceutical dosage as they can be administered via either the oral or the parenteral route. Their palatability makes them a product of choice for geriatric and pediatric patients. Get 10% Customization on this Research Report :-https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=19845828 Europe to hold the largest share in the global market during the forecast period of 2020–2025. Geographically, the pharmaceutical packaging equipment market is segmented into North America, Europe, the Asia Pacific, Latin America, and Middle East & Africa. Growth in the European market is driven majorly by the high pharmaceutical production, increasing demand for flexible packaging equipment by major pharmaceutical manufacturers, and the rising focus on product diversification by companies, driving the demand for innovative packaging equipment. Regulatory changes are also compelling pharmaceutical manufacturers to replace their older equipment with new equipment to adhere to the changing standards. The prominent players in this market are Syntegon Technology (Germany), IMA S.p.A. (Italy), Körber AG (Germany), Uhlmann Group (Germany), OPTIMA Packaging Group (Germany), Romaco Holding (Germany), Marchesini Group (Italy), ACG Worldwide (India), Coesia S.p.A. (Italy) and MULTIVAC Group (Germany).
Medical store in Faridabad | Medicine Delivery In Faridabad
In today’s era of science and technology, we forgot to take care of ourselves. That is why we all need medications to heal ourselves & to stay active. When the things are so easy now that you do not need to go anywhere. Now, many stores are providing services to deliver medicine at home. Dava Bharti medical store in Faridabad is one among them. We try to get all essential medicines in your comfort zone. If you are looking for a medical store near me for home delivery, then you have come to the right place. What Is “Dava Bharti Pharmacy : Dava Bharti is the most trusted online pharmacy in Faridabad started in the year 2007 as a retail chain store and provided online medicine delivery in Faridabad. We provide all types of medicines, such as Ayurvedic medicines, homeopathic medicines at just your door step. Our pharmacy is managed by the experienced staff who have more than 10 year's experience in the pharmaceutical industry. We have 1000+ satisfied customers across Faridabad. We are committed to superior quality and prices. Apart from dealing in medicines, Dava Bharti provides medical equipments, surgical, health checker devices, dispensary items etc online with free home delivery. For Medicines:- Shop Now App Link:- https://play.google.com/store/apps/details?id=com.davaBharti Why You Should Choose Us: Dava Bharti has now become a trustworthy name for online medicine delivery to me. Following are some reasons that why you should choose us to buy medicines online: You can buy a variety of medicines All products available at one store 10+ years experienced staff 100% organic & natural products Qualified staff Amazing offers & discounts Products & Medicines Delivered By Dava Bharti: With the increasing trust of our customers, we thought of dealing with a variety of products & medicines as well. As a result, we have started to sell a different type of products online in Faridabad. Below is the list of our products: Ayurvedic medicines Homeopathy medicines Patanjali ayurvedic medicines Personal care products Fitness Products Beauty & Wellness products Baby care products Ayurvedic Medicines: Due to modern lifestyle and stressful living, “Ayurveda” has now become a major concern among the society. People are now more aware of Ayurveda and Satvic lifestyle. Gradually people are adopting Ancient satvik lifestyle & Ayurvedic medications to stay healthy. Dava Bharti provides the service of Ayurvedic medicine delivery in Faridabad. We provide Himalaya Ayurvedic products, herbal medicines & Baidhnath medicines. Jiva amla juice, aloe vera juice, Ayurvedic lauki juice, Patanjali Gloy juice, Ayurvedic neem juice, Jamun ras, Baidyanath amla juice is some of the Ayurvedic medicines. We provide online medicine delivery in Faridabad of these Ayurvedic medicines. Homeopathic Medicines: Homeopathic medicine can cure many illnesses and help you feel happy, motivated and set you on your way to fulfilling your creative potential. Homeopathy is generally based on more than 200-year-old medical science based on the principles. Some of these are: The first is “The laws of similar”. According to this, your disease first will match by the thousands of medicines after this that medicine will be given to you. The reason is like cures like. The second important principle is “Individualization” It means that every patient is unique that is why their treatment would be also differ. Homeopathy considers your nature, features, likes, dislikes, etc. On these features, Homeopathy treats you. The third is “Long-term results” according to this principle, Homeopathy gives you permanent and long-term results. The reason is fast results medicines give you online temporary relief, but homeopathic medicines cure you from the inside. That is why it works slowly. Dava Bharti is well the known online pharmacy in Faridabad, provide all the Homeopathic medicines at your door-step. Patanjali Ayurvedic Medicines: We give free service to deliver medicine at home. For the beautiful skin and healthy life, Patanjali has made herbal medicines which are chemical free or have very less harmful effects. Patanjali aloe vera ras, amla juice, Jamun juice, Dash mool kwath for female’s menstrual cycle, Giloy juice, Pachak methi nimbu, Liv D tablets and syrup for the healthy liver. If you are looking for a medical store near me for home delivery, you can trust Dava Bharti.
Animal Growth Promoters and Performance Enhancers Market worth $21.4 billion by 2026 - Exclusive Report by MarketsandMarkets™
According to the new market research report "Animal Growth Promoters and Performance Enhancers Market by Type (Antibiotic and Non-antibiotic (Hormones, Acidifiers, Feed Enzymes, Probiotics & Prebiotics, Phytogenic)), Animal Type (Poultry, Porcine, Livestock, Aquaculture) - Global Forecast to 2026", published by MarketsandMarkets™, the global market is projected to reach USD 21.4 billion by 2026 from USD 16.2 billion in 2021, at a CAGR of 5.7%. Browse in-depth TOC on "Animal Growth Promoters and Performance Enhancers Market" 118 – Tables 53 – Figures 245 – Pages Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=137134167 Animal health products, including growth promoters and performance enhancers, are types of drugs and chemicals used for animal growth. These enhancers help to digest food more effectively and enable animals to grow faster, which, in turn, help to improve productivity. Growth in the animal growth promoters and performance enhancers market is majorly driven by the rising demand for animal consumption and consumption of livestock-based products, rising global demand for naturally produced growth promoters, and rising animal epidemics and climate change. However, a ban on antibiotics in different nations and stringent regulations restricting the use of antibiotics and hormones for growth promotion in animals are expected to restrain the growth of the animal growth promoters and performance enhancers market during the forecast period. By Type, the non-antibiotic growth promoters and performance enhancers segment is expected to account for the largest share of the animal growth promoters and performance enhancers market The non-antibiotic growth promoters and performance enhancers segment accounted for the largest share of the animal growth promoters and performance enhancers market in 2020. The large share of this segment can be attributed to the economic benefits of these products, the wide range of substances with applications in different production animals, environmental sustainability, and the increased number of regulations on antibiotics and hormones. Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=137134167 On the basis of animal type, poultry segment is expected to account for the largest share of the animal growth promoters and performance enhancers market The poultry segment accounted for the largest share of the global animal growth promoters and performance enhancers market. The large market share of this segment can be attributed to the increasing demand for poultry meat and eggs, rising novel diet approaches, and increasing antibiotic phase-outs resulting in the development of alternatives. Asia Pacific to dominate the animal growth promoters and performance enhancers market during the forecast period Asia Pacific region accounted for the largest market share, followed by North America with a share in 2020. The large share of the Asia Pacific region can be attributed to the strong animal products industry in this region, huge population generating greater domestic meat demand, comparatively relaxed regulatory scenario, and government efforts to encourage animal producers. Prominent players in the Animal Growth Promoters and Performance Enhancers Market include are Cargill, Incorporated (US), Royal DSM N.V. (Netherlands), Elanco Animal Health Incorporated (US), Boehringer Ingelheim Group (Germany), Merck & Co., Inc (US), Alltech Corporation (US), Archer-Daniels-Midland Company (ADM) (US), Vetoquinol S.A. (France), Bupo Animal Health Pty Ltd. (South Africa) and Novus International, Inc. (US). Browse Related Reports: Animal Antibiotics and Antimicrobials Market by Product (Tetracycline, Penicillin, Sulfonamide, Macrolide, Cephalosporin, Lincosamide), Mode of Delivery (Premixes, Oral Solution, Injection), Animal (Food producing & Companion) - Global Forecast to 2026 https://www.marketsandmarkets.com/Market-Reports/animal-antimicrobials-antibiotics-market-25161353.html
#30303 SAP Evaluation DOT Near Me| SAP Evaluation
SAP Evaluation: It is crucial for substance abuse applications to have an awesome knowledge of the dependency procedure if you want to offer high-quality viable take care to their clients. This knowledge can come from each private revel in and expert training. SAP Evaluation DOT Near Me gives a huge variety of offerings, which may be tailor-made to satisfy the precise wishes of the person. These offerings can assist people to conquer dependency, abuse substances, and/or increase more healthy habits. These offerings may be furnished in a medical or rehabilitative setting. Substance abuse companies can assist people to discover the assets they want to get easily and sober. Substance abuse companies are in a completely unique role to assist people with addictions. They have the revel in and information to offer help and assistance. Many substance abuse companies additionally provide counseling, which may be extraordinarily useful for the ones in want, and FMCSA SAP Near Me may be a high-quality assist for them. DOT Qualified SAP presents offerings to people who are suffering from alcohol and drug dependency via the FMCSA SAP Program. They can assist the individual get the remedy they want to get sober and live that way. Providers also can offer help for the duration of the recuperation procedure. Substance abuse will have a widespread effect on each person and the community. Substance abuse companies can play a crucial position in assisting to remedy those problems.
Flow Cytometry Market worth $6.3 billion by 2026 - Exclusive Report by MarketsandMarkets™
According to the new market research report "Flow Cytometry Market by Product (Analyzer, Sorter, Reagents, Consumables, Software), Technology, Application (Research, Clinical - Cancer Diagnostics, Hematology), End User (Academia, Research Labs, Pharma, Biotech, Hospitals) - Global Forecast to 2026", published by MarketsandMarkets™, the market is projected to reach USD 6.3 billion by 2026 from USD 4.3 billion in 2021, at a CAGR of 8.1%. Browse in-depth TOC on "Flow Cytometry Market" 263 – Tables 40 – Figures 282 – Pages Download PDF Brochure :- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65374584 The Growth in the flow cytometry market is largely driven by the rising global incidence and prevalence of HIV/AIDS and cancer, growing adoption of flow cytometry techniques in research and academia, growing public-private initiatives in the fields of immunology and immuno-oncology research, technological advancements, increasing incorporation of AI platforms in flow cytometry workflows, and increasing advancements in flow cytometry software. However, the high cost of flow cytometry products is a major factor hampering the growth of the market. The bead-based flow cytometry segment is expected to grow at the highest CAGR during the forecast period On the basis of technology, the global flow cytometry market is segmented into cell-based and bead-based flow cytometry. The bead-based flow cytometry segment is estimated to witness the highest growth during the forecast period. This technology offers various procedural advantages over other cell-based assays, such as the capacity to detect multiple analytes (also known as multiplexing), high reproducibility, stability, and speed. Cancer diagnostic segment hold the largest share of the flow cytometry for clinical application market in 2020 In this report, the flow cytometry market for clinical applications is segmented into organ & tissue transplantations, cancer diagnostics, immunodeficiency diseases, hematology, and other clinical applications. Flow cytometry can be applied to cancer studies at every stage by measuring the amount of DNA in cancer cells, analyzing tumor cell proliferation, and immunophenotyping hematological malignancies. In addition, flow cytometry tools are used to determine the malignancy of a tumor by analyzing and enumerating a number of chromosomes and can thus be used to detect cancerous cells. Request Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=65374584 The Asia Pacific region is the fastest-growing region of the flow cytometry market in 2020. In 2020, the Asia Pacific region accounted for the fasted growing region of the market. The APAC market is expected to offer significant growth opportunities to key market players during the forecast period. Countries in this region are witnessing sustained growth in their GDPs and the disposable incomes of their middle-class population. This is expected to replicate into growth in healthcare spending, research infrastructure modernization, and increased penetration of advanced technologies (including advanced flow cytometry technologies) for research and clinical applications. The major players operating in the flow cytometry market are Becton, Dickinson and Company (US), Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Luminex Corporation (US), Agilent Technologies, Inc. (US), Sony Group Corporation (Japan), Bio-Rad Laboratories, Inc. (US), Miltenyi Biotec GmbH (Germany), Enzo Biochem, Inc. (US), Sysmex Corporation (Japan), bioMérieux S.A. (France), Cytonome/ ST, LLC (US), Sartorius AG (Germany), Cytek Biosciences, Inc. (US), Union Biometrica, Inc. (US), Apogee Flow Systems Ltd. (UK), Stratedigm, Inc. (US), NanoCellect Biomedical, Inc. (US), On-chip Biotechnologies, Co., Ltd. (Japan), NEXCELOM BIOSCIENCE LLC (US), BennuBio Inc. (US), ORFLO Technologies (US), Bay Biosciences Co., Ltd. (Japan), BioLegend, Inc. (US), and CytoBuoy B.V (Netherlands). Browse Related Reports: Cell Analysis Market by Product [Microscope, Spectrophotometers, Flow cytometry (Software, Accessories)], Process (Cell Viability, Cell Proliferation, Signal Transduction), End User (Pharma, Research, Biotechnology Companies) - Global Forecast to 2024
External Fixators Market Opportunities In 2028: USD 1.16 Bn Industry On An Upward Trend
External Fixators Industry Overview The global external fixators market size was valued at USD 854.5 million in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 4.0% from 2021 to 2028. The growing burden of chronic diseases is boosting the need for surgical interventions, which is fueling the growth of the market. Moreover, the continuously rising target patient population along with rising cases of car accidents are promoting the market growth. With the first wave of the COVID-19 pandemic, many countries made the required decision to postpone all non-emergency surgical procedures to free up people and resources to care for COVID-19 patients. As stated by a new study circulated in the Annals of Surgery, the charge of halting major elective surgery all through the COVID-19 is projected to be USD 22.3 billion in the U.S. Gather more insights about the market drivers, restrains and growth of the Global External Fixators Market Approximately 10 million individuals in the U.K. were waiting for surgical procedures in 2020, up from 4 million before the COVID-19 pandemic hit. Amongst them are almost 100,000 patients whose joint replacement surgeries were annulled all through the first COVID-19 movement. Therefore, in the coming years, it is estimated that the market will recover rapidly after the resumption of surgical procedures at full force. The industry players also reported a decline in sales in the first two quarters of 2020 and then a gradual recovery afterward. For instance, Nuvasive reported a 70% case volume decline in 2020 Q2 from the prior year. Orthofix reported 6% revenue growth in 2020 Q3 from the last year. Clinics began offering online video appointments while some opened with limited operations, using screening protocols and curbside services, which are expected to propel the market growth gradually. There is an overall increase in the prevalence of chronic disorders, such as diabetes, which is also boosting the demand for external fixators. Throughout the world, it is estimated that every 30 seconds a leg is amputated and 85% of these amputations were the results of a diabetic foot ulcer. According to a 2019 study by the CDC, 27.7% of adults who have arthritis are obese and 33.7% of them are also diabetic. According to the American Diabetes Association, there was around a 64% increase in minor Nontraumatic Lower-Extremity Amputations (NLEA) and a 30% increase in major NLEAs, between 2009 & 2018.  Browse through Grand View Research's Medical Devices Industry Research Reports. Dental Flap Surgery Market: The global dental flap surgery market was valued at USD 4.75 billion in 2021 and is anticipated to expand at a compound annual growth rate (CAGR) of 7.2% from 2022 to 2030. Automated Visual Field Analyzer Market: The global automated visual field analyzer market size was valued at USD 149.38 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 6.52% from 2022 to 2030.  External Fixators Market Segmentation Grand View Research has segmented the global external fixators market on the basis of product, fixation type, end-user, application, and region: External Fixators Product Outlook (Revenue, USD Million, 2016 - 2028) Manual Computer-aided External Fixators Fixation Type Outlook (Revenue, USD Million, 2016 - 2028) Unilateral & Bilateral Circular Hybrid & Others External Fixators End-user Outlook (Revenue, USD Million, 2016 - 2028) Hospitals Ambulatory Surgical Centers (ASCs) Orthopedic and Trauma Centers External Fixators Application Outlook (Revenue, USD Million, 2016 - 2028) Orthopedic Deformities Fracture Fixation Infected Fracture Limb Correction Others External Fixators Regional Outlook (Revenue, USD Million, 2016 - 2028) North America Europe Asia Pacific Latin America Middle East and Africa Market Share Insights January 2021: Stryker acquired OrthoSensor, Inc., a frontrunner in the digital evolution for total joint replacement, to strengthen its market position. August 2020: Smith+Nephew launched ARIA, a digital platform and application for connecting the delivery of patient care with providers, expanding the company’s offerings. Key Companies profiled: Some of the prominent players in the global external fixators market include: Johnson & Johnson Services, Inc. (DePuy Synthes) Stryker Zimmer Biomet Smith+Nephew Orthofix Medical, Inc. Ortho-SUV Ltd. Response Ortho Tasarimmed Tıbbi Mamuller San. Tic A.Åž. Auxein Medical Acumed Order a free sample PDF of the External Fixators Market Intelligence Study, published by Grand View Research.  About Grand View Research Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc. Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: sales@grandviewresearch.com Web: https://www.grandviewresearch.com Follow Us: LinkedIn | Twitter
Veterinary Imaging Market worth $2.3 billion by 2026 - Exclusive Report by MarketsandMarkets™
According to the new market research report "Veterinary Imaging Market by Product (Ultrasound (2D, 3D, Doppler), X-Ray (CR, DR), MRI, CT, Software, Reagent), Therapeutic Area (Orthopedics, Gynecology, Oncology, Dentistry), Animal (Small, Large), End User (Hospital, Clinic) - Global Forecast to 2026", published by MarketsandMarkets™, the global market is projected to reach USD 2.3 billion by 2026 from USD 1.6 billion in 2021, growing at a CAGR of 7.0% during the forecast period. The growth of the global veterinary imaging market during the forecast period is mainly driven by the increasing rate of companion animal population, rising demand for pet insurance and an increasing amount of animal health expenditure, growing number of veterinary practitioners and their rising income levels in developed economies, rising demand for animal-derived food products, and growing prevalence of animal diseases. Emerging markets, such as India and China, and growing companion animal ownership in the APAC region are also factors expected to offer significant growth opportunities for players in the market. On the other hand, lack of animal healthcare awareness, a severe shortage of skilled veterinarians, and the high cost of imaging instruments in emerging countries are factors expected to restrain the overall market growth, to a certain extent, during the forecast period. Browse in-depth TOC on "Veterinary Imaging Market" 331 – Tables 63 – Figures 371 – Pages Download PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=80889726 The impact of the COVID-19 pandemic and the lockdowns it triggered is clearly visible on various markets, including the veterinary imaging market. In 2020 and early 2021, the overall growth of various sectors was heavily impacted, specifically in countries with a high incidence rate of COVID-19, such as India, Brazil, China, the US, and several European countries (including Russia, Italy, the UK, and Spain). The COVID-19 pandemic is expected to have a temporary negative impact on the market or its growth during the forecast period. The outbreak of COVID-19 originated from a meat market in Wuhan (China), which has negatively affected the consumption of food products derived from animal sources. Unfavorable changes in regulations and guidelines are hampering the growth of this market. The closing down of manufacturing facilities due to lockdowns, disruptions in supply chains, and recruitment challenges for clinical trials have further impacted the growth of the overall veterinary imaging market. Furthermore, trade barriers in various regions are also expected to restrain the growth of the market. The Veterinary Imaging Instruments segment holds the largest market share during the forecast period. On the basis of products, the global market is segmented into veterinary imaging instruments, reagents, and software. In 2020, the instruments segment accounted for the largest share of the global veterinary imaging market. Growth in this product segment can largely be attributed to the increasing adoption of digital imaging owing to the high-quality images provided by these instruments for disease diagnosis. Request Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=80889726 In the therapeutic area segment, Orthopedics & Traumatology segment holds the largest market share during the forecast period Based on the type of therapeutic area, the market is segmented into cardiology, neurology, oncology, orthopedics & traumatology, dentistry, obstetrics & gynecology, and other therapeutic areas, which include veterinary ophthalmology and nephrology. In 2020, the orthopedics and traumatology segment accounted for the largest share of the global veterinary imaging market. The largest share of this segment can be attributed to the growing incidence of bone injuries and the increasing prevalence of arthritis, lameness diseases, and joint disorders in animals. In the animal type segment, small companion animals segment is expected to grow at the largest share in the veterinary imaging market Based on the type of animal, the market is segmented into small companion animals, large animals, and other animals. The small companion animals segment accounted for the largest market share in 2020. This can be attributed to the increasing adoption of companion pets, increasing focus on the safety of companion animals, growing expenditure on animal health and preventative care, increasing demand for pet insurance, aging pet population, and growing technological advancements in imaging modalities. The small companion animals segment is also expected to register the highest growth during the forecast period. In the end user segment, Veterinary Clinics & Diagnostic Centers segment is expected to account for the largest share in the veterinary imaging market On the basis of end users, the global market is segmented into veterinary clinics and diagnostic centers and veterinary hospitals and academic institutions. Veterinary clinics and diagnostic centers are the major end users in the market and accounted for a share in 2020. The large share of this segment is primarily attributed to the increasing number of veterinary practices and the growing number of veterinarians. APAC is expected to grow at the highest growth rate in 2020 The Asia Pacific region is expected to register the highest CAGR during the forecast period. Growing pet adoption, increasing awareness about animal health, and growing per capita animal health expenditure, especially in India and China, are contributing to the growth of the APAC market. Key players in the veterinary imaging market The prominent players in the market are GE Healthcare (US), Agfa-Gevaert N.V. (Belgium), Carestream Health (US), Esaote S.p.A (Italy), IDEXX Laboratories, Inc. (US), Mindray Medical International Limited (China), Canon Inc. (Japan), Heska Corporation (US), Siemens Healthineers (Germany), FUJIFILM Holdings Corporation (Japan), Konica Minolta Inc. (Japan), Samsung Electronics Co., Ltd. (South Korea), E.I. Medical Imaging (US), IMV imaging (UK), SEDECAL (Spain). Other players in the veterinary imaging market are Clarius Mobile Health (Canada), Shenzhen Ricso Technology Co. Ltd. (China), DRAMIÑSKI S.A. (Poland), Epica Animal Health (US), and ClearVet Digital Radiography Systems (US), MinXray Inc. (US), Hallmarq Veterinary Imaging (UK), Shantou Institute of Ultrasonic Instruments Co., Ltd (China), Sonoscape Medical Corp. (China), and Reproscan (US).
RELIABLE AGENCY FOR NURSES, SUPPORT WORKER OR CARER IN THE UK.
A company that specializes in hiring medical experts is called PraiseHealthCenter. In order to provide home health care in  London and UK area, we are seeking for nursing assistant, support worker, or caretaker. In the UK, nursing is one of the occupations with the highest demand. More health professionals are required as a result. The people in North Somerset and the surrounding areas who require your service will be connected to you by Us Praise Healthcare. So why are you still waiting? Register right away. To fill care roles in North Somerset and our other service regions, Praise Healthcare is always looking for new hires. Our working hours are flexible and can be made to suit you specifically. We work hard to place you in jobs that are fulfilling and diversified. Contact Praise Healthcare if you pride yourself on being a hard worker and the best at what you do. We are hiring for a variety of professions, including live-in caregivers, nurses, and support staff. You will be able to actively build your career in a welcoming setting within a developing industry thanks to the breadth of our prospects. Why should you to join us? The benefits and reasons to collaborate with us are listed below. 1. We pay at exceptional rates. 2. You can accept as little or as much work as you choose because we can provide an infinite number of shifts. 3. We'll make sure that you have the enthusiastic and supportive support of our dedicated management staff. 4. To accommodate your demands, we provide various shift arrangements and working hours, including night shifts and part-time jobs. 5. There will be lots of chances for you to advance in rewarding and interesting professions. 6. We can provide temporary placements for extended or short periods of time, depending on your needs. 7. and more Our mission is to offer nursing, support, and care services that are compassionate, secure, and that contribute to everyone living healthier lives. As a direct recruiting company in the UK, we provide full help at every level of the procedure and will promptly put you in the right direction. A conducive and suitable work can be found with us for those looking to pursue a nursing career in the UK, which boasts the most advanced healthcare sector in the world. You'll be astounded to find that every year, thousands of nurses are hired. Therefore, employers in the UK's healthcare industry are seeking candidates with the ability to maintain composure under pressure, sympathy, and strong and amiable communication skills.